Trial · NCT02202161
Results by group1,071
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 1,071
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | Placebo | Fasting, Day 7 | -6.58 | Standard Deviation 16.357 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 10 mg BID | Fasting, Day 7 | -8.25 | Standard Deviation 6.500 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 20 mg BID | Fasting, Day 7 | -1.40 | Standard Deviation 23.050 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 30 mg BID | Fasting, Day 7 | -38.56 | Standard Deviation 24.744 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 60 mg BID | Fasting, Day 7 | -34.38 | Standard Deviation 19.398 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 90 mg BID | Fasting, Day 7 | -24.78 | Standard Deviation 13.414 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | Sitagliptin 50 mg BID | Fasting, Day 7 | -24.54 | Standard Deviation 33.955 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | Placebo | Fasting, Day 14 | -10.00 | Standard Deviation 19.207 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 10 mg BID | Fasting, Day 14 | -22.75 | Standard Deviation 11.354 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 20 mg BID | Fasting, Day 14 | -16.20 | Standard Deviation 28.709 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 30 mg BID | Fasting, Day 14 | -48.67 | Standard Deviation 32.650 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 60 mg BID | Fasting, Day 14 | -36.13 | Standard Deviation 23.117 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 90 mg BID | Fasting, Day 14 | -40.22 | Standard Deviation 19.156 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | Sitagliptin 50 mg BID | Fasting, Day 14 | -38.38 | Standard Deviation 16.439 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | Placebo | WM AUC(0-24 hour), Day 7 | 3.91 | Standard Deviation 20.668 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 10 mg BID | WM AUC(0-24 hour), Day 7 | -12.14 | Standard Deviation 11.828 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 20 mg BID | WM AUC(0-24 hour), Day 7 | -7.01 | Standard Deviation 17.262 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 30 mg BID | WM AUC(0-24 hour), Day 7 | -25.33 | Standard Deviation 25.819 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 60 mg BID | WM AUC(0-24 hour), Day 7 | -21.47 | Standard Deviation 18.419 | Mg/deciliter |
| Change From Baseline in Derived Plasma Glucose Parameter Over a 24-hour Period-fasting and Weighted Mean Glucose Area Under Curve (AUC[0-24 Hour]) | GSK2330672 90 mg BID | WM AUC(0-24 hour), Day 7 | -14.84 | Standard Deviation 18.569 | Mg/deciliter |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02202161/results